Molecular biology of gynecological cancer (Review)

Kenzo Sonoda

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.

Original languageEnglish
Pages (from-to)16-22
Number of pages7
JournalOncology Letters
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 2016

Fingerprint

Molecular Biology
Neoplasms
Growth
Proteomics
Cell Death
Neoplasm Metastasis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Molecular biology of gynecological cancer (Review). / Sonoda, Kenzo.

In: Oncology Letters, Vol. 11, No. 1, 01.2016, p. 16-22.

Research output: Contribution to journalReview article

Sonoda, Kenzo. / Molecular biology of gynecological cancer (Review). In: Oncology Letters. 2016 ; Vol. 11, No. 1. pp. 16-22.
@article{fe6dd548d66a417ea6ef876d3f3ec02f,
title = "Molecular biology of gynecological cancer (Review)",
abstract = "Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.",
author = "Kenzo Sonoda",
year = "2016",
month = "1",
doi = "10.3892/ol.2015.3862",
language = "English",
volume = "11",
pages = "16--22",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Molecular biology of gynecological cancer (Review)

AU - Sonoda, Kenzo

PY - 2016/1

Y1 - 2016/1

N2 - Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.

AB - Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.

UR - http://www.scopus.com/inward/record.url?scp=84948807776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948807776&partnerID=8YFLogxK

U2 - 10.3892/ol.2015.3862

DO - 10.3892/ol.2015.3862

M3 - Review article

AN - SCOPUS:84948807776

VL - 11

SP - 16

EP - 22

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -